Summary
L0T Chart
What Makes GE HealthCare (GEHC) a New Strong Buy Stock
GE HealthCare (GEHC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
GEHC vs. BSX: Which Stock Is the Better Value Option?
Investors interested in Medical - Products stocks are likely familiar with GE HealthCare Technologies (GEHC) and Boston Scientific (BSX). But which of these two stocks is more attractive to value investors?
GE HealthCare: This Drop Represents A Buying Opportunity
GE HealthCare Technologies delivered strong Q2 results, beating revenue and earnings expectations, and raised full-year guidance despite a sharp share price drop. The company is trading at a significant discount to peers, offering substantial upside potential even at the low end of industry valuation multiples. Management is actively mitigating tariff impacts, investing in innovation, and launching new products to drive future growth and operational efficiency.
GE HealthCare Technologies Inc. Dividends
 GEHC 2 weeks ago Announced | Quarterly | $0.04 Per Share |
| GEHC 3 months ago Paid | Quarterly | $0.04 Per Share |
| GEHC 7 months ago Paid | Quarterly | $0.04 Per Share |
| GEHC 9 months ago Paid | Quarterly | $0.03 Per Share |
| GEHC 19 Jul 2024 Paid | Quarterly | $0.03 Per Share |
GE HealthCare Technologies Inc. Earnings
| 29 Oct 2025 (In 2 months) Date | | 1.05 Cons. EPS | - EPS |
| 30 Jul 2025 Date | | 0.91 Cons. EPS | - EPS |
| 30 Jul 2025 Date | | 1.15 Cons. EPS | 1.06 EPS |
| 30 Apr 2025 Date | | - Cons. EPS | - EPS |
| 13 Feb 2025 Date | | 1.26 Cons. EPS | 1.45 EPS |
| GEHC 2 weeks ago Announced | Quarterly | $0.04 Per Share |
| GEHC 3 months ago Paid | Quarterly | $0.04 Per Share |
| GEHC 7 months ago Paid | Quarterly | $0.04 Per Share |
| GEHC 9 months ago Paid | Quarterly | $0.03 Per Share |
| GEHC 19 Jul 2024 Paid | Quarterly | $0.03 Per Share |
| 29 Oct 2025 (In 2 months) Date | | 1.05 Cons. EPS | - EPS |
| 30 Jul 2025 Date | | 0.91 Cons. EPS | - EPS |
| 30 Jul 2025 Date | | 1.15 Cons. EPS | 1.06 EPS |
| 30 Apr 2025 Date | | - Cons. EPS | - EPS |
| 13 Feb 2025 Date | | 1.26 Cons. EPS | 1.45 EPS |
GE HealthCare Technologies Inc. (L0T) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
What is the earnings per share?
When is the next earnings date?
Has GE HealthCare Technologies Inc. ever had a stock split?
GE HealthCare Technologies Inc. Profile
| Medical - Healthcare Information Services Industry | Healthcare Sector | Peter J. Arduini CEO | XSTU Exchange | US36266G1076 ISIN |
| US Country | 53,000 Employees | 25 Jul 2025 Last Dividend | - Last Split | 4 Jan 2023 IPO Date |
Overview
GE HealthCare Technologies Inc. is a globally recognized company deeply engaged in the healthcare sector, providing a wide range of products, services, and digital solutions aimed at improving patient care. With operations spread across the United States, Canada, and other international markets, the company commits itself to the development, manufacture, and marketing of innovative medical technologies. The organizational structure of GE HealthCare Technologies Inc. is divided into four primary segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics, each dedicated to addressing specific medical needs and advancing the field of medical diagnostics and patient care. Having evolved from GE Healthcare Holding LLC in December 2022, the company is now based in Chicago, Illinois, and continues to leverage its broad portfolio to facilitate the diagnosis, treatment, and monitoring of patients worldwide.
Products and Services
- Imaging
This segment provides a comprehensive range of imaging technologies such as molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. These advanced imaging solutions play a crucial role in diagnosing and managing various health conditions, enhancing the efficiency and effectiveness of medical treatments.
- Ultrasound
GE HealthCare Technologies Inc. offers a wide array of ultrasound devices and solutions designed for screening, diagnosis, treatment, and monitoring of diseases in numerous clinical areas. This includes radiology, primary care, women's health, cardiovascular, along with point of care and handheld ultrasound devices, and products for surgical visualization and guidance. Ultrasound technology facilitates non-invasive diagnostics and therapeutic procedures, making it an essential tool in modern healthcare.
- Patient Care Solutions
The company's offerings under this segment encompass a variety of medical devices, consumables, services, and digital solutions aimed at improving patient outcomes. The portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, and maternal infant care products, alongside a range of consumables and services. These solutions are integral to providing comprehensive care in various medical settings, from emergency rooms to intensive care units and beyond.
- Pharmaceutical Diagnostics
Specializing in diagnostic agents for radiology and nuclear medicine, this segment supplies essential products for CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound imaging. The products include contrast media pharmaceuticals that improve the visibility of tissues during diagnostic scans and molecular imaging agents or radiopharmaceuticals labeled with radioisotopes for detailed imaging studies. These diagnostic agents are pivotal in detecting and monitoring a wide range of diseases, aiding clinicians in formulating effective treatment plans.
Contact Information
